Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Editing02:23

RNA Editing

10.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.2K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

3.0K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.0K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

7.4K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular basis of oocyte cytoplasmic lattice assembly.

Nature·2026
Same author

Mechanistic insights into RNA cleavage by human Argonaute2-siRNA complex.

Cell research·2025
Same author

Mitochondrial Proteome Reveals Metabolic Tuning by Restricted Insulin Signaling to Promote Longevity in <i>Caenorhabditis elegans</i>.

Biology·2025
Same author

Spatiotemporal single-cell architecture of gene expression in the Caenorhabditis elegans germ cells.

Cell discovery·2025
Same author

Argonaute CSR-1A promotes H3K9me3 maintenance to protect somatic development in offspring.

Nucleic acids research·2025
Same author

Structural insights into RNA cleavage by PIWI Argonaute.

Nature·2025

Related Experiment Video

Updated: Apr 9, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

36.4K

Boosting prime editing with engineered non-canonical pegRNAs.

Guo-Qing Fang1, Yuan Deng1,2, Xin-Yuan Lyu1

  • 1Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.

Nature Biomedical Engineering
|April 7, 2026
PubMed
Summary

Engineered prime editing (PE) using non-canonical guide RNAs (npegRNAs) significantly boosts precise genome editing efficiency. This advance enhances therapeutic gene correction and holds promise for future gene therapy applications.

More Related Videos

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

6.6K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.8K

Related Experiment Videos

Last Updated: Apr 9, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

36.4K
CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

6.6K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.8K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies
  • Biotechnology

Background:

  • Prime editing (PE) offers precise genetic modification capabilities via prime editing guide RNAs (pegRNAs).
  • Current PE ribonucleoprotein (RNP) delivery systems exhibit limited genomic editing efficiency, hindering therapeutic use.
  • The reverse transcription template and primer binding site (RTT-PBS) are typically located at the 3' end of CRISPR-Cas guide RNAs.

Purpose of the Study:

  • To engineer the PE complex for enhanced efficiency using non-canonical pegRNAs (npegRNAs).
  • To integrate the RTT-PBS within the single guide RNA loops of npegRNAs.
  • To evaluate the therapeutic potential of npegRNA-mediated PE for gene correction.

Main Methods:

  • Structure-guided engineering of the PE complex.
  • Design and utilization of non-canonical pegRNAs (npegRNAs) with integrated RTT-PBS.
  • Testing of npegRNA-mediated PE in various genomic sites, cell types, and a tyrosinaemia mouse model.

Main Results:

  • npegRNAs demonstrated significantly enhanced precise editing rates across diverse genomic locations and cell lines.
  • PE RNP delivery with npegRNAs achieved substantially higher editing yields (26.8-fold over canonical pegRNAs).
  • npegRNA-mediated RNPs improved disease-relevant mutation installation efficiency up to 123-fold in human cells.

Conclusions:

  • Structure-guided engineering with npegRNAs represents a robust strategy to improve PE efficiency.
  • npegRNAs exhibit increased resistance to exonuclease degradation, potentially enhancing in vivo targeting.
  • This approach shows significant potential for advancing therapeutic gene editing applications.